| Market Cap | ₹8,893Cr |
| ROE | 42.11% |
| P/E Ratio(TTM) | 22.45 |
| EPS(TTM) | 172.04 |
| P/B Ratio | 10.33 |
| Dividend Yield | 3.03% |
| Industry P/E | 32.50 |
| Book Value | 373.70 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
| Managing Director | Mr. Rodolfo Hrosz |
| Founded | 1956 |
| NSE Symbol | SANOFI |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 37.40 | ||
| GlaxoSmithKline Pharmaceuticals | NA (0.00%) | 42.08 | ||
| Pfizer | NA (0.00%) | 26.38 | ||
| Astrazeneca Pharma India | NA (0.00%) | 109.48 |